Blog Hero

How MacuMira Offers New Hope for People Living with Dry AMD 

Book Now
Close up of an older persons eye

Receiving a diagnosis of dry age-related macular degeneration (dry AMD) can feel overwhelming. It often comes with uncertainty about the future of your vision and the ability to continue enjoying the activities you love. For years, the standard approach has been watchful waiting, with limited options to halt the disease’s progression. Today, there is new hope. 

An innovative treatment called MacuMira® is changing eye care providers’ approach to dry AMD, offering a proactive way to improve vision and quality of life—and you just may qualify

Understanding Dry Age-Related Macular Degeneration

Dry age-related macular degeneration is a common eye condition and a leading cause of vision loss for people over the age of 50. It affects the macula, the part of the retina responsible for sharp, central vision needed for reading, driving, and recognizing faces.

The “dry” form of AMD is the most common, accounting for about 80–90% of all cases. It occurs when the macula thins over time as part of the aging process, and tiny clumps of protein called drusen begin to grow. These deposits can damage the light-sensitive cells in the macula, leading to a slow and gradual loss of central vision. While your peripheral (side) vision usually remains unaffected, the loss of central clarity can significantly impact daily life.

Common symptoms of dry AMD include:

  • Blurry or distorted central vision.
  • Straight lines appear wavy.
  • Difficulty reading or seeing fine details.
  • Needing brighter light for close-up tasks.
  • Colours appear less vibrant.

For a long time, treatment options were limited to nutritional supplements and lifestyle changes aimed at slowing the disease’s progression. Patients were often told there was little to be done but to monitor the condition. That reality is now changing.

What Is MacuMira? 

MacuMira is the first clinically proven and authorized treatment in Canada for dry AMD. It represents a significant shift from passive monitoring to active intervention. This innovative, non-invasive therapy is designed not just to slow the disease, but to help improve visual function.

Unlike treatments that require injections or surgery, MacuMira uses a gentle, microcurrent stimulation delivered by a qualified eye care professional. The therapy is designed with patient safety and comfort as the top priorities, providing a pain-free and straightforward experience.

How Does MacuMira Work?

The science behind MacuMira is both innovative and straightforward. The treatment delivers a precise, low-level electrical current to the retina. This stimulation works by:

  • Improving cellular function: The microcurrent may help enhance the function of the retinal cells, improving their ability to process light and transmit visual signals to the brain.
  • Increasing blood flow: The therapy can promote better circulation in the small blood vessels that nourish the macula, delivering vital oxygen and nutrients.
  • Reducing inflammation: By addressing underlying inflammation, MacuMira helps create a healthier environment for the retinal cells to function and repair.

This multifaceted approach helps revitalize the macula, leading to measurable improvements in vision for many patients.

Senior person testing their vision with an eye doctor

How MacuMira Can Improve Your Vision & Renew Your Life

The most significant benefit of MacuMira is its ability to offer tangible results. Patients who undergo the treatment report meaningful improvements that allow them to reclaim their independence and enjoy their favourite activities once again.

Here are some of the ways MacuMira can help:

  • Improved visual acuity: Many patients experience an improvement in their ability to read the eye chart. This translates to sharper, clearer vision for everyday tasks.
  • Enhanced contrast sensitivity: Colours may appear brighter and more vivid, and it can become easier to distinguish objects from their backgrounds. This is particularly helpful in low-light conditions.
  • Reduced drusen: Clinical studies have shown that MacuMira can lead to a reduction in the size and volume of drusen, the protein deposits associated with dry AMD progression.
  • Better quality of life: The ability to read a book, see the faces of loved ones more clearly, or drive with greater confidence can have a profound impact on your overall well-being and independence.

MacuMira is a testament to how modern technology can provide safe, practical solutions for conditions that were once considered untreatable. It offers a new path forward—one defined by hope and proactive care.

Take the Next Step Toward Clearer Vision

Living with dry AMD no longer has to be a passive experience. With MacuMira, you have the opportunity to actively improve your vision and protect your sight for the years to come. This revolutionary treatment offers a renewed sense of optimism for patients and their families.

If you or a loved one has been diagnosed with dry AMD, we encourage you to learn more about this groundbreaking therapy. Discuss with your eye care provider whether you are a suitable candidate for the treatment. To find a provider or get more information, visit our website. It’s time to stop just watching your vision change and start doing something to improve it.

instagram facebook facebook2 pinterest twitter google-plus google linkedin2 yelp youtube phone location calendar share2 link star-full star star-half chevron-right chevron-left chevron-down chevron-up envelope fax